Kirmizis Lab

a yellow sign that says we 're hiring ALT: a yellow sign that says we 're hiring

Spread the news! We are excited to expand our research team, working on cellular senescence, at the Cancer Research UK Cambridge Institute, University of Cambridge.

jobs.cam.ac.uk/job/52026/
jobs.cam.ac.uk/job/52027/

H2A.X N-terminal acetylation is a newly identified NAA40-mediated modification that is responsive to UV irradiation - Epigenetics & Chromatin Background N-terminal acetylation (Nt-Ac), mediated by N-terminal acetyltransferases (NATs) is one of the most abundant protein modifications occurring approximately in 80% of all eukaryotic proteins....

📢 Our new paper is out! @kirmizislab.bsky.social
H2A.X is N-terminally acetylated by NAA40–a novel histone mod responsive to UV irradiation. Thanks to all authors @bonalditiziana.bsky.social @drksquare.bsky.social, anonymous reviewers and @springernature.com #Epigenetics&Chromatin Editorial team.

Acetylhistidine in our blood can prevent kidney disease and is produced by the HisAT (NAT16) enzyme displaying a rare double-GNAT structure. Great efforts by Matti Myllykoski and the rest of the team at @unibergen.bsky.social to get this published. #acetyltransferase www.nature.com/articles/s41...

Congrats to our postdoc EvelinaCharidemou for receiving the Cyprus Young Researcher Award in Life Sciences awarded by the Research Innovation Foundation for her exciting work at the crossroad of #epigenetics and #metabolism Wishing her continued success as she progresses her career as independent PI

Please RS/RT. #GordonConference "Histone and DNA Modifications" Program is now online 🍾 #epigenetics #chromatin #histones 20.-25. July. Il Ciocco 🇮🇹
Register now: ➡️ shorturl.at/AtAjz
Exciting speaker lineup, many slots for talks selected from abstracts